NuView Life Sciences, Inc

Changing the way cancer is diagnosed and treated

Founded 2006

Park City, United States 4 employees Private Equity Total: $90.00M Biotechnology

NuView Life Sciences, Inc. (founded: 2005) is at the forefront of revolutionizing cancer diagnosis and treatment with the slogan "Changing the way cancer is diagnosed and treated." As a clinical stage precision oncology company, NuView is pioneering a breakthrough approach by targeting the over-expressed Vasoactive Intestinal Peptide/Pituitary Adenylate Cyclase-activating Peptide Receptor on the surface of various cancer types at the onset of oncogenesis. The company's NV-VPAC1 has shown promising results in clinical trials for the confirmation of cancer both in vitro and in vivo. Notably, this innovative agent is not limited to just identification, but can also be utilized to deliver existing therapeutics and new alpha and beta emitters, accentuating its versatility and potential impact in oncology. NuView's strategic focus on creating a Theranostics solution for patients and clinicians by pairing existing imaging and therapeutic radionuclides with their proprietary agent demonstrates a forward-thinking approach towards addressing unmet clinical needs. The latest milestone in the company's journey is the substantial $90.00M Private Equity Round investment on 03 August 2020, indicating the confidence of investors such as Global Emerging Markets in NuView's innovative vision and potential to transform cancer care. By seamlessly integrating cutting-edge science with clinical application, NuView Life Sciences is poised to make a significant impact in the biotechnology industry.

Funding Stage	Amount	Investors	Lead Investors	Date
Private Equity Round	$90.00M	1	Global Emerging Markets	03 Aug 2020

Funding Stage

Amount

Investors

Lead Investors

Date

Private Equity Round

$90.00M

Global Emerging Markets

03 Aug 2020

FAQ About NuView Life Sciences, Inc

Changing the way cancer is diagnosed and treated

NuView Life Sciences, Inc was founded in 2006.

NuView Life Sciences, Inc is headquartered in Park City, United States.

NuView Life Sciences, Inc operates in Biotechnology. Its work centres on Precision Oncology, Cancer Diagnostics, Theranostics and Precision Medicine.

NuView Life Sciences, Inc has approximately 4 employees.

NuView Life Sciences, Inc has completed 1 funding round, raising a total of $90.00M. The latest funding stage is Private Equity.

Top alternatives and competitors to NuView Life Sciences, Inc include Avenzo Therapeutics, Viewpoint Molecular Targeting, Inc., Cvergenx, Fusion Pharmaceuticals, BoomRay Pharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

NuView Life Sciences, Inc and Avenzo Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

NuView Life Sciences, Inc

General Information

Discover More

About NuView Life Sciences, Inc

Funding Rounds & Investors (1)

NuView Life Sciences, Inc Alternatives & Competitors

FAQ About NuView Life Sciences, Inc